human therapeutic antibodies (Merus)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namehuman therapeutic antibodies (Merus)

Drug Alias Nameanti-EGFR/HER-2/HER-3 mAbs (Merus)

ClassificationBiologics > Protein drugs > Recombinant proteinBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human

Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 antagonistsReceptor tyrosine-protein kinase erbB-3 antagonistsEpidermal growth factor receptor erbB1 antagonists

TargetsEpidermal growth factor receptor erbB1Receptor tyrosine-protein kinase erbB-3Receptor protein-tyrosine kinase erbB-2

Therapy Area/IndicationsNeoplasmsVirus Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNetherlands

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesMerus Nv

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMerus Nv

Active IndicationsN/A

Inactive IndicationsNeoplasmsVirus Diseases

Other Information

ATC CodeN/A